Stereotaxis(STXS)
ST.LOUIS, MOBiotechnology
Focus: Stereotaxis is a public medical device company specializing in remote magnetic catheter navigation systems for cardiac ablation and interventional procedures. The company is a niche player in electrophysiology with ~$27M in annual revenue.
Profile data last refreshed 15h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Stereotaxis
AI assessmentNot HiringNo open roles listed right now. Follow Stereotaxis to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Stereotaxis's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
4/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Revenue
$27M
Pipeline & Clinical Trials
Cardiac ablation using the MAGiC Ablation Catheter
Supraventricular Tachycardia (SVT)Clinical Trials (1)
NCT07812818MAGiC - Congenital Heart DIsease
N/AHelp build intelligence for Stereotaxis
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.